Touat, Mehdi
Brigham and Women's Hospital · Centre National de la Recherche Scientifique · Inserm · Sorbonne Université · Assistance Publique – Hôpitaux de Paris · Pitié-Salpêtrière Hospital · Institut du Cerveau
4 papers on CoChatORCID 0000-0002-5910-7799
Most cited papers
- Verified
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Mellinghoff, I. K., van den Bent, M. J., Blumenthal, D. T., Touat, M., Peters, K. B., Clarke, J., Mendez, J., Yust-Katz, S., Welsh, L., Mason, W. P., et al. (2023) · New England Journal of Medicine
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 814
- Verified
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
de Botton, S., Mondesir, J., Willekens, C., & Touat, M. (2016) · Journal of Blood Medicine
Glioma Diagnosis and TreatmentCancer, Hypoxia, and Metabolism
Cited by 220
- Verified
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
van den Bent, M. J., French, P. J., Brat, D., Tonn, J. C., Touat, M., Ellingson, B. M., Young, R. J., Pallud, J., von Deimling, A., Sahm, F., et al. (2024) · Neuro-Oncology
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 88
- Verified
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
Spitzer, A., Gritsch, S., Nomura, M., Jucht, A., Fortin, J., Raviram, R., Weisman, H. R., Gonzalez Castro, L. N., Druck, N., Chanoch-Myers, R., et al. (2024) · Cancer Cell
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 69
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free